A drug to treat advanced prostate cancer should be given to patients on the NHS, a health watchdog has said.
Abirateron, marketed as Zytiga, can extend the lives of late-stage cancer sufferers by more than three months.
The National Institute for Health and Clinical Excellence (Nice) revised its recommendations after fresh information from manufacturer Janssen, and the new draft guidance was welcomed by experts.
More top news
Read Sadiq Khan's full victory speech, as the Tooting MP promised to be a mayor for "all Londoners".
Former footballer Frank Worthington has denied he is suffering from Alzheimer's - a day after his daughter said he was.
A list of results for London Mayor and the London Assembly